abstract |
The invention relates to an ex vivo method of diagnosing or predicting an arterial disease, or a risk of arterial disease, in a subject, which method comprises detecting a mutation in the MYH11 gene or protein (myosin heavy polypeptide 11 of smooth muscle cells), wherein said mutation is indicative of an arterial disease or of a risk of arterial disease. |